BRAF and thyroid gland undifferentiated (anaplastic) carcinoma: Furthermore, a pooled analysis of data from 29 studies showed that BRAF V600E mutations occurred in 44% of patients with PTC and 24% of patients with anaplastic thyroid carcinoma (ATC).56